Business Context and Reporting Period
Company: Garden Stage Limited (GSIW)
Filing Type: Form 20-F (Annual Report)
Reporting Period: Fiscal year ended March 31, 2026 (FY 2026)
Business Overview: A Cayman Islands holding company operating primarily in Hong Kong through subsidiaries I Win Securities (Type 1 dealing in securities) and I Win Asset Management (Type 4 advising and Type 9 asset management). The company provides placing/underwriting, brokerage, advisory, and asset management services. In November 2025, the company acquired Mental Form (BVI) Limited and its subsidiary Mental Form (HK) Limited to enter the humanoid robotics sector, though production and sales commenced only in April 2026.
Key Financial Metrics
| Metric | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| Total Revenue | $7.28 million | $5.47 million | $1.41 million |
| Net Loss | $(13.84) million | $(4.32) million | $(4.59) million |
| Loss Per Share (Basic & Diluted) | $(1.38) | $(0.47) | $(0.49) |
| Cash and Restricted Cash | $17.52 million | $7.89 million | $8.94 million |
| Total Assets | $41.93 million | $15.90 million | N/A |
| Total Liabilities | $17.70 million | $9.20 million | N/A |
| Shareholders' Equity | $24.22 million | $6.70 million | N/A |
Note: Share and per-share data have been retroactively adjusted for a 200-for-1 reverse share split of Class A Ordinary Shares effective March 6, 2026.
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 33.2% to $7.28 million, driven by significant growth in underwriting/placement income (up 1,164.5%), handling income (up 924.5%), and brokerage commissions (up 222.2%). This was partially offset by a 48.6% decline in introducing and referral income due to the non-recurrence of a one-off fee in FY 2025.
- Net Loss Expansion: Net loss widened significantly to $13.84 million (up 220.5% from FY 2025). The increase was primarily driven by:
- Amortization: $1.02 million in amortization of intangible assets acquired in the November 2025 robotics acquisition.
- Professional Fees: Increased to $5.85 million (up 658.7%), largely due to $3.67 million in share-based compensation for consultants.
- Brokerage/Clearing Fees: Increased to $4.11 million due to higher transaction volumes.
- Capital Structure: The company completed multiple registered direct offerings and a private placement in FY 2026, raising approximately $20.6 million in net proceeds from equity issuances. A 200-for-1 reverse share split was executed on Class A shares.
- Acquisition: Acquired Mental Form (BVI) for $10.75 million (cash and stock) to acquire intellectual property for robotics, accounted for as an asset acquisition.
Guidance, Outlook, and Risks
- Outlook: Management plans to expand securities brokerage, underwriting, and asset management services. The robotics business (humanoid robots) is a new, unproven line of business with production commencing in April 2026. Future results depend on the commercialization of these activities.
- Internal Control Weaknesses: The company identified material weaknesses in internal control over financial reporting, specifically a lack of personnel with sufficient U.S. GAAP expertise. Remediation measures include hiring qualified staff and establishing policy manuals.
- Regulatory Risks (PRC/HK): Significant risks exist regarding the potential application of PRC laws (cybersecurity, data security, overseas listing regulations) to the company's Hong Kong operations. The company currently believes it is not subject to CSRC filing requirements but acknowledges uncertainty.
- HFCAA/Delisting Risk: The company's auditor (J&S Associate PLT) is based in Malaysia and subject to PCAOB inspection. However, the company notes risks if the PCAOB determines it cannot inspect auditors in the future, which could lead to delisting under the Holding Foreign Companies Accountable Act.
- Customer Concentration: High concentration risk exists; the top five customers accounted for 59% of revenue in FY 2026, with the largest single customer contributing 32%.
Investor Verification Checklist
- Revenue Quality: Verify the sustainability of the "Introducing and Referral" income stream, which dropped significantly after a one-off transaction in FY 2025.
- Robotics Viability: Assess the commercial viability and capital requirements of the new robotics business, which has not yet generated revenue.
- Internal Controls: Monitor the remediation of material weaknesses in financial reporting and the effectiveness of new U.S. GAAP-compliant personnel.
- Regulatory Compliance: Confirm the company's status regarding PRC regulatory filings (CSRC/CAC) and the ongoing SFC review of I Win Securities.
- Share Dilution: Review the impact of the 200-for-1 reverse split and the significant equity issuances in FY 2026 on future dilution and voting power (Class B shares hold 100 votes per share).